<?xml version="1.0"?><root><article><title Title="article xml" direction="ltr">International Journal of Endocrinology and Metabolism</title><title_fa Title="Title_fa">مجله‌ي بین المللی غدد درون‌ريز و متابوليسم</title_fa><short_title Title="Short_title">Int J Endocrinol Metab</short_title><subject Title="Subject">Medical Sciences</subject><web_url Title="Web_url">http://www.ijem.org</web_url><journal_hbi_system_id Title="Journal_hbi_system_id"></journal_hbi_system_id><journal_hbi_system_user Title="Journal_hbi_system_user"></journal_hbi_system_user><journal_id_issn Title="Journal_id_issn">1726-913X</journal_id_issn><journal_id_issn_online Title="Journal_id_issn_online"></journal_id_issn_online><journal_id_pii Title="Journal_id_pii"></journal_id_pii><journal_id_doi Title="Journal_id_doi"></journal_id_doi><journal_id_iranmedex Title="Journal_id_iranmedex"></journal_id_iranmedex><journal_id_magiran Title="Journal_id_magiran"></journal_id_magiran><journal_id_sid Title="Journal_id_sid"></journal_id_sid><journal_id_nlai Title="Journal_id_nlai"></journal_id_nlai><journal_id_science Title="Journal_id_science"></journal_id_science><language Title="Language">en</language><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics</articletitle><authors Title="Authors">Tildesley HD&lt;sup&gt;a,b&lt;/sup&gt;, Wise JS&lt;sup&gt;b&lt;/sup&gt;, Mazanderani AB&lt;sup&gt;a&lt;/sup&gt;, Aydin CA&lt;sup&gt;b&lt;/sup&gt;, Fraser TS&lt;sup&gt;b&lt;/sup&gt;, Yu E&lt;sup&gt;c&lt;/sup&gt;<author><full_name>Tildesley HD&lt;sup&gt;a</full_name><suffix /><email /><code /><affiliation /></author><author><full_name>b&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Wise JS&lt;sup&gt;b&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Mazanderani AB&lt;sup&gt;a&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Aydin CA&lt;sup&gt;b&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Fraser TS&lt;sup&gt;b&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Yu E&lt;sup&gt;c&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">&lt;sup&gt;a&lt;/sup&gt;Division of Endocrinology, St. Pauls Hospital, &lt;sup&gt;b&lt;/sup&gt;Department of Medicine, and &lt;sup&gt;c&lt;/sup&gt;Department of Statistics, University of British Columbia, Vancouver, British Colombia, Ca</articleinstitution><articlecategory Title="ArticleCategory">Original Article</articlecategory><articleabstract Title="ArticleAbstract">In 1998 the definition of type 2 diabetes was revised, in particular the fasting plasma glucose (FPG) diagnostic level was lowered from 7.8 mmol/L to 7.0 mmol/L. The purpose of this study was to examine the effects of this change on patient demographics. 
Materials &amp;amp;amp;amp;amp; Methods: We reviewed data from 1700 type 2 diabetes patients, who attended the St. Paul’s Hospital Diabetes Teaching and Train-ing Centre before (group 1) and after (group 2) the definition change. Demographical data from a baseline and follow-up were analyzed. The frequencies of patients in groups and cohorts &amp;amp;amp;amp;lt;60 years of age and ≥60 years of age were calculated and HbA1c data was analyzed. 
Results: Compared to Group 1, Group 2 was younger, had a significantly lower mean HbA1c level (7.3% vs 8.1%, p&amp;amp;amp;amp;lt;0.0001), blood pressure (127/78 vs 133/82 mmHg, p&amp;amp;amp;amp;lt;0.05) and cholesterol (5.2 vs 5.5 mmol, p&amp;amp;amp;amp;lt;0.05) and was more often treated with multiple medications (p&amp;amp;amp;amp;lt;0.001). Pa-tients in Group 2 were significantly more likely to meet the target HbA1c level of 7.0% than pa-tients in Group 1 (p&amp;amp;amp;amp;lt;0.0001). It was also found that at baseline, patients ≥60 years old in Group 2 had significantly lower HbA1c values than those &amp;amp;amp;amp;lt;60 years old (p&amp;amp;amp;amp;lt;0.001). 
Conclusion: Since the change in the definition of type 2 diabetes, a greater frequency of patients presented with lower mean HbA1c values and met target HbA1c levels. Patients ≥60 years old initially presented with lower HbA1c levels than those &amp;amp;amp;amp;lt;60 years old.</articleabstract><articlekeyword Title="ArticleKeyword">Type 2 diabetes, Fasting plasma glucose, 1998 clinical practice guidelines</articlekeyword><articleruningtitle Title="ArticleRuningTitle">Definition of type 2 diabetes</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Hugh D. Tildesley</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">8/18/2009 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">11/5/2009 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">hught@istar.ca</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlevolumenumber Title="ArticleVolumeNumber">7</articlevolumenumber><articlestartpage Title="ArticleStartPage">51</articlestartpage><articleendpage Title="ArticleEndPage">55</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article></root>